[Recommendations of diagnosis and treatment of Takayasu's arteritis in China].

Jiang, L D; Ma, L L; Xue, Y; Pan, X; He, L; Zhao, Yan

Jiang, L D; Ma, L L; Xue, Y; Pan, X; He, L; Zhao, Yan.

Afiliação

Jiang LD; Department of Rheumatology, Zhongshan Hospital, Fudan University, Evidence-Based Medicine Center, Fudan University, Shanghai 200032, China.
Ma LL; Department of Rheumatology, Zhongshan Hospital, Fudan University, Evidence-Based Medicine Center, Fudan University, Shanghai 200032, China.
Xue Y; Department of Rheumatology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Pan X; Department of Hematology and Rheumatology, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi 832008, China.
He L; Department of Rheumatology and Immunology, First Affiliated Hospital of Xi'an JiaoTong University, Xi'an 710061, China.
Zhao Y; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, State Key Laboratory of Complex Severe and Rare Diseases, Key Lab

Zhonghua Nei Ke Za Zhi ; 61(5): 517-524, 2022 May 01.

Article em Zh | MEDLINE | ID: mdl-35488601

Assuntos

Arterite de Takayasu; China; Humanos; Prevalência; Prognóstico; Índice de Gravidade de Doença; Arterite de Takayasu/diagnóstico; Arterite de Takayasu/terapia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Arterite de Takayasu Tipo de estudo: Diagnostic_studies / Guideline / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: Zh Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google